Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Currently, there is evidence supporting the use of either an angiotensin receptor blocker or an angiotensin-converting enzyme inhibitor in the primary-prevention context. However, in the secondary ...

In contrast, ARBs would be expected to inhibit the biologic effects of angiotensin II more completely than ACE inhibitors, since they block the pathway more distally at the level of the receptor ...

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 ...

Current treatment methods for C3 glomerulopathy (C3G) help support kidney function and suppress immune system activity. Emerging therapies interrupt the proteins responsible for disease activity ...

Angiotensin Receptor Blockers ARBs also help reduce protein in the urine, slow declines in kidney function, and decrease blood pressure. GLP-1 Receptor Agonists By supporting weight loss and ...

The P2X3 receptor antagonist was discovered as part of a strategic R&D alliance with Evotec that began in 2012 with a focus on endometriosis and was brought to a close in 2017.